Journal Article Summary

The article investigates how naltrexone, an opioid antagonist, affects conditioned pain modulation (CPM) in healthy individuals, particularly focusing on the role of pain catastrophizing. CPM is a process where pain from one stimulus can be reduced by another painful stimulus, and understanding this mechanism is important for developing better pain management strategies. The study aims to clarify whether the pain modulation observed during CPM is influenced by the body's natural opioids and how individual differences in pain perception, particularly catastrophizing, might affect this relationship.

In the study, 33 healthy volunteers participated in a placebo-controlled trial where they received either naltrexone or a placebo before undergoing pain tests involving heat and cold stimuli. The results showed that while the placebo significantly reduced pain during the CPM test, naltrexone blocked this pain reduction, indicating that the pain inhibition was at least partially dependent on the body's endogenous opioids. Additionally, individuals with low to moderate levels of pain catastrophizing experienced a complete reversal of pain modulation with naltrexone, while those with high catastrophizing maintained their pain inhibition, suggesting different underlying mechanisms at play.

The study has several limitations, including the use of a single dose of naltrexone, which may not fully saturate opioid receptors, and the lack of consideration for body weight in dosing. These factors could affect the drug's efficacy in different individuals. Patients and caregivers should discuss these findings with healthcare professionals, especially regarding how individual psychological factors like catastrophizing can influence pain perception and management. Understanding these dynamics can help tailor pain treatment approaches more effectively.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. King Christopher D., Goodin Burel, Kindler Lindsay L., Caudle Robert M., Edwards Robert R., Gravenstein Nikolaus, Riley Joseph L., Fillingim Roger B.. Reduction of conditioned pain modulation in humans by naltrexone: an exploratory study of the effects of pain catastrophizing. Journal of behavioral medicine 2012. DOI: 10.1007/s10865-012-9424-2. PMID: 22534819. PMCID: PMC3774309.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]